Duration of Response and Progression-Free Survival With Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients With Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind. J of Skin 2020, 4 (5), s68. https://doi.org/10.25251/skin.4.supp.67.